Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to the Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms

NCT03349320 is registered in ClinicalTrials.gov with Federal University of Minas Gerais as lead sponsor.

NCT NCT03349320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03349320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to the Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms
Lead sponsor
Federal University of Minas Gerais
Phase
Observational
Overall status
Completed
Start date
June 30, 2009
Completion date
March 31, 2013
Enrollment
37 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

late onset alzheimer disease